Lingchen Wang
Shuguang, 201203, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Shen-Shuai-Ⅱ Recipe ameliorates chronic kidney disease-induced myocardial injury via inhibition of the IL-18/IL-18R1/MyD88 pathway.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 01, 2025
Shen-Shuai-II-Recipe suppresses hypoxia-induced oxidative stress and ferroptosis via Nrf2 activation to ameliorate renal fibrosis in chronic kidney disease.
Journal: Journal of ethnopharmacology
Published: July 15, 2025
Worldwide hotspots and trends in stem cell therapy for kidney disease in the last decade: a bibliometric and visualization analysis from 2015 to 2024.
Journal: Frontiers in immunology
Published: April 28, 2025
Astragaloside IV attenuates fatty acid-induced renal tubular injury in diabetic kidney disease by inhibiting fatty acid transport protein-2.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: June 07, 2024
Linking renal hypoxia and oxidative stress in chronic kidney disease: Based on clinical subjects and animal models.
Journal: Biomolecules & biomedicine
Published: January 12, 2024
Shen-Shuai-II-Recipe inhibits tubular inflammation by PPARα-mediated fatty acid oxidation to attenuate fibroblast activation in fibrotic kidneys.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 25, 2023
Icariside II prevents kidney fibrosis development in chronic kidney disease by promoting fatty acid oxidation.
Journal: Phytotherapy research : PTR
Published: August 05, 2023
Icariin attenuates renal fibrosis in chronic kidney disease by inhibiting interleukin-1β/transforming growth factor-β-mediated activation of renal fibroblasts.
Journal: Phytotherapy research : PTR
Published: June 17, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026